Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating R
| Image |  |
|---|---|
| Description | scientific article published on 24 August 2010 |
| Author/s |
author: Børge G. Nordestgaard Jacques Genest jr. John J. P. Kastelein Robert J Glynn Paul Ridker Jean G Macfadyen Wolfgang Koenig |
| Publication date | August 24, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |